EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV-2 Transmission during High-Altitude Field Studies

Mirjam Grimm, Lucie Ziegler, Annina Seglias, Maamed Mademilov, Kamila Magdieva, Gulzada Mirzalieva, Aijan Taalaibekova, Simone Suter, Simon R Schneider, Fiona Zoller, Vera Bissig, Lukas Reinhard und 14 weitere

High Altitude Medicine & Biology · 01.09.2024 · 25 (3) · 197-204

DOI: 10.1089/ham.2023.0128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift High Altitude Medicine & Biology, online erschienen am 04.09.2024. Verfasst von Mirjam Grimm und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, University Hospital of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: COVID-19, Altitude, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Grimm, Mirjam, Lucie Ziegler, Annina Seglias, Maamed Mademilov, Kamila Magdieva, Gulzada Mirzalieva, Aijan Taalaibekova, Simone Suter, Simon R. Schneider, Fiona Zoller, Vera Bissig, Lukas Reinhard, Meret Bauer, Julian Müller, Tanja L. Ulrich, Arcangelo F. Carta, Patrick R. Bader, Konstantinos Bitos, Aurelia E. Reiser, Benoit Champigneulle, Damira Ashyralieva, Philipp M. Scheiwiller, Silvia Ulrich, Talant M. Sooronbaev, Michael Furian, and Konrad E. Bloch. SARS-CoV-2 Transmission during High-Altitude Field Studies. High Alt Med Biol . 25:197–204, 2024.

Background

Throughout the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic, virus transmission during clinical research was of concern. Therefore, during high-altitude field studies performed in 2021, we took specific COVID-19 precautions and investigated the occurrence of SARS-CoV-2 infection.

Methods

From May to September 2021, we performed studies in patients with chronic obstructive pulmonary disease (COPD) and in healthy school-age children in Kyrgyzstan in high-altitude facilities at 3,100 m and 3,250 m and at 760 m. The various implemented COVID-19 safety measures included systematic SARS-CoV-2 rapid antigen testing (RAT). Main outcomes were SARS-CoV-2-RAT-positive rate among participants and staff at initial presentation (prevalence) and SARS-CoV-2-RAT-positive conversion during and within 10 days after studies (incidence).

Results

Among 338 participants and staff, SARS-CoV-2-RAT-positive prevalence was 15 (4.4%). During mean ± SD duration of individual study participation of 3.1 ± 1.0 day and within 10 days, RAT-positive conversion occurred in 1/237(0.4%) participants. Among staff working in studies for 31.5 ± 29.3 days, SARS-CoV-2-RAT-positive conversion was 11/101(10.9%). In all 338 individuals involved in the studies over the course of 15.6 weeks, the median SARS-CoV-2-RAT-positive incidence was 0.00%/week (quartiles 0.00; 0.64). Over the same period, the median background incidence among the total Kyrgyz population of 6,636 million was 0.06%/week (0.03; 0.11), p = 0.013 (Wilcoxon rank sum test).

Conclusions

Taking precautions by implementing specific safety measures, SARS-CoV-2 transmission during clinical studies was very rare, and the SARS-CoV-2 incidence among participants and staff was lower than that in the general population during the same period. The results are reassuring and may help in decision-making on the conduct of clinical research in similar settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AltitudeSARS-CoV-2HumansMaleFemaleAdultMiddle Aged

Stichwörter der Autor:innen

COVID-19SARS-CoV-2clinical trialhigh altitudemountainvirus transmission

Autor:innen und Institutionen

  • Department of Respiratory Medicine, University Hospital of Zurich, Zurich, Switzerland.
  • Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland.
  • Department of Respiratory Medicine, National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyz Republic.
  • Université Grenoble Alpes, Grenoble, France.
  • National Institute of Public Health, Ministry of Health, Bishkek, Kyrgyz Republic.

ORCID-Profile: Benoit Champigneulle, Silvia Ulrich, Michael Furian, Konrad E Bloch

Zitieren

APA

Grimm, M., Ziegler, L., Seglias, A., Mademilov, M., Magdieva, K., Mirzalieva, G., Taalaibekova, A., Suter, S., Schneider, S. R., Zoller, F., Bissig, V., Reinhard, L., Bauer, M., Müller, J., Ulrich, T. L., Carta, A. F., Bader, P. R., Bitos, K., Reiser, A. E., …, & Bloch, K. E. (2024). SARS-CoV-2 Transmission during High-Altitude Field Studies. High Altitude Medicine & Biology, 25(3), 197-204. https://doi.org/10.1089/ham.2023.0128

Vancouver

Grimm M, Ziegler L, Seglias A, Mademilov M, Magdieva K, Mirzalieva G, et al. SARS-CoV-2 Transmission during High-Altitude Field Studies. High Altitude Medicine & Biology. 2024;25(3):197-204. doi:10.1089/ham.2023.0128

BibTeX
@article{Grimm2024,
  author = {Grimm, Mirjam and Ziegler, Lucie and Seglias, Annina and Mademilov, Maamed and Magdieva, Kamila and Mirzalieva, Gulzada and Taalaibekova, Aijan and Suter, Simone and Schneider, Simon R and Zoller, Fiona and Bissig, Vera and Reinhard, Lukas and Bauer, Meret and Müller, Julian and Ulrich, Tanja L and Carta, Arcangelo F and Bader, Patrick R and Bitos, Konstantinos and Reiser, Aurelia E and Champigneulle, Benoit and Ashyralieva, Damira and Scheiwiller, Philipp M and Ulrich, Silvia and Sooronbaev, Talant M and Furian, Michael and Bloch, Konrad E},
  title = {SARS-CoV-2 Transmission during High-Altitude Field Studies},
  journal = {High Altitude Medicine & Biology},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {197--204},
  doi = {10.1089/ham.2023.0128}
}
Kostenlos starten →